171 related articles for article (PubMed ID: 2933464)
1. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
2. Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia.
Weiss L; Weigensberg M; Morecki S; Bar S; Cobbold S; Waldmann H; Slavin S
Cancer Immunol Immunother; 1990; 31(4):236-42. PubMed ID: 2379219
[TBL] [Abstract][Full Text] [Related]
3. Stability of Chimerism in Non-Obese Diabetic Mice Achieved By Rapid T Cell Depletion Is Associated With High Levels of Donor Cells Very Early After Transplant.
Lin J; Chan WFN; Boon L; Anderson CC
Front Immunol; 2018; 9():837. PubMed ID: 29740442
[TBL] [Abstract][Full Text] [Related]
4. Recipient leukocyte infusion enhances the local and systemic graft-versus-neuroblastoma effect of allogeneic bone marrow transplantation in mice.
Willems L; Fevery S; Sprangers B; Rutgeerts O; Lenaerts C; Ibrahimi A; Gijsbers R; Van Gool S; Waer M; Billiau AD
Cancer Immunol Immunother; 2013 Nov; 62(11):1733-44. PubMed ID: 24081484
[TBL] [Abstract][Full Text] [Related]
5. Depletion of foxp3(+) T cells abrogates tolerance of skin and heart allografts in murine mixed chimeras without the loss of mixed chimerism.
Shinoda K; Akiyoshi T; Chase CM; Farkash EA; Ndishabandi DK; Raczek CM; Sebastian DP; Pelle PD; Russell PS; Madsen JC; Colvin RB; Alessandrini A
Am J Transplant; 2014 Oct; 14(10):2263-2274. PubMed ID: 25155089
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse).
Zeng YJ; Ricordi C; Tzakis A; Rilo HL; Carroll PB; Starzl TE; Ildstad ST
Transplantation; 1992 Feb; 53(2):277-83. PubMed ID: 1738920
[TBL] [Abstract][Full Text] [Related]
7. Specific eradication of micrometastases by transfer of tumour-immune T cells from major-histocompatibility-complex congenic mice.
Schirrmacher V; von Hoegen P; Griesbach A; Schild HJ; Zangemeister-Wittke U
Cancer Immunol Immunother; 1991; 32(6):373-81. PubMed ID: 1826094
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific tolerance induction in organ transplantation via mixed splenocytes chimerism.
Yamazaki S; Kanamoto A; Takayama T
Clin Exp Immunol; 2013 Aug; 173(2):173-8. PubMed ID: 23656242
[TBL] [Abstract][Full Text] [Related]
9. Immunomagnetic T-lymphocyte depletion (ITLD) of rat bone marrow using OX-19 monoclonal antibody.
Hoffman AL; Makowka L; Cramer DV; Cai X; Pascualone A; Banner BF; Sheahan DG; Rettinger P; Starzl TE
J Invest Surg; 1989; 2(3):241-51. PubMed ID: 2487253
[TBL] [Abstract][Full Text] [Related]
10. Induction of tolerance through mixed chimerism.
Sachs DH; Kawai T; Sykes M
Cold Spring Harb Perspect Med; 2014 Jan; 4(1):a015529. PubMed ID: 24384815
[TBL] [Abstract][Full Text] [Related]
11. The anti-CD2 monoclonal antibody BTI-322 generates unresponsiveness by activation-associated T cell depletion.
Xu Y; Kolber-Simonds D; Hope JA; Bazin H; Latinne D; Monroy R; White-Scharf ME; Schuurman HJ
Clin Exp Immunol; 2004 Dec; 138(3):476-83. PubMed ID: 15544625
[TBL] [Abstract][Full Text] [Related]
12. Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients.
Xu H; Chilton PM; Tanner MK; Huang Y; Schanie CL; Dy-Liacco M; Yan J; Ildstad ST
Blood; 2006 Nov; 108(10):3611-9. PubMed ID: 16888094
[TBL] [Abstract][Full Text] [Related]
13. Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model.
Kappel BJ; Pinilla-Ibarz J; Kochman AA; Eng JM; Hubbard VM; Leiner I; Pamer EG; Heller G; van den Brink MR; Scheinberg DA
Blood; 2006 Mar; 107(5):2045-51. PubMed ID: 16269613
[TBL] [Abstract][Full Text] [Related]
14. Studies on the recovery from tolerance to tumor antigens. I. Bone marrow cells from tolerant hosts are not rendered tolerant, but provide potential to reconstitute tumor-specific effector T cell clones.
Fujiwara H; Sato S; Kosugi A; Fukuzawa M; Hamaoka T
Cancer Immunol Immunother; 1987; 24(2):113-20. PubMed ID: 3493844
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option?
Zöller M
Cancer Immunol Immunother; 2004 Aug; 53(8):659-76. PubMed ID: 15067430
[TBL] [Abstract][Full Text] [Related]
16. Tolerance in intestinal transplantation.
Sykes M
Hum Immunol; 2024 May; 85(3):110793. PubMed ID: 38580539
[TBL] [Abstract][Full Text] [Related]
17. Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease.
Brandon JA; Perez J; Jennings CD; Cohen DA; Sindhava VJ; Bondada S; Kaplan AM; Bryson JS
Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G602-13. PubMed ID: 20634434
[TBL] [Abstract][Full Text] [Related]
18. Influence of Housing Temperature and Genetic Diversity on Allogeneic T Cell-Induced Tissue Damage in Mice.
Enriquez J; McDaniel Mims B; Stroever S; Dos Santos AP; Jones-Hall Y; Furr KL; Grisham MB
Pathophysiology; 2023 Nov; 30(4):522-547. PubMed ID: 37987308
[TBL] [Abstract][Full Text] [Related]
19. The Effects of IL-23/IL-18-Polarized Neutrophils on Renal Ischemia-Reperfusion Injury and Allogeneic-Skin-Graft Rejection in Mice.
Wu C; Xu J; Zhang Z; Wei D; Xu Y; Zhao Y
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137369
[TBL] [Abstract][Full Text] [Related]
20. Study on the Extrapolability of Current Tumorgenicity Test With Mice by Comparing the Syngeneic or Allogeneic Mouse Transplantation Model.
Tamura T; Tahara T; Inoue M; Nanjo R; Onoe H; Yamamoto T; Kawamata S
Stem Cells Transl Med; 2024 Jun; 13(6):572-581. PubMed ID: 38554123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
